Efficacy, Safety, & Pharmacokinetics of ES-481 in Adult Patients With

See also
Status	Clinical Trial	Phase
Completed	`NCT04661241` - Mapping the Target for the MRgFUS Treatment of Tremor	N/A
Recruiting	`NCT03074422` - Effectiveness and Reliability of Hypnosis in Stereotaxy	N/A
Active, not recruiting	`NCT03935581` - Safety and Feasibility of ExAblate Neuro System to Perform Auto-Focusing Echo Imaging in Patients With Essential Tremor	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT04661241 - Mapping the Target for the MRgFUS Treatment of Tremor

N/A

Recruiting

NCT03074422 - Effectiveness and Reliability of Hypnosis in Stereotaxy

N/A

Active, not recruiting

NCT03935581 - Safety and Feasibility of ExAblate Neuro System to Perform Auto-Focusing Echo Imaging in Patients With Essential Tremor

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05234762
Study type	Interventional
Source	ES Therapeutics Australia Pty Ltd
Contact	Robert Niecestro, PhD
Phone	+1-917-733-5311
Email	rniecestro@estherapeutics.com
Status	Recruiting
Phase	Phase 2
Start date	November 21, 2021
Completion date	December 31, 2023

Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms